Showing results (31-40 of 106) with videos related to
Sort By:
Pageof 11
Antioxidants & Redox Signaling|July 4, 2012
NADPH oxidases in heart failure: poachers or gamekeepers?Min Zhang, Alessia Perino, Alessandra Ghigo, et al.Oncogenesis|January 9, 2021
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexiaValentina Rausch, Valentina Sala, Fabio Penna, et al.Small Gtpases|May 6, 2015
Crossroads of PI3K and Rac pathwaysCarlo C Campa, Elisa Ciraolo, Alessandra Ghigo, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 9, 2023
Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapyAlessandra Ghigo, Chiara De Santi, Merrill Hart, et al.European Journal of Medicinal Chemistry|January 25, 2021
Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectivesValentina Sala, Sophie Julie Cnudde, Alessandra Murabito, et al.Current Treatment Options in Oncology|February 6, 2021
Metabolic Aspects of Anthracycline CardiotoxicityMichele Russo, Angela Della Sala, Carlo Gabriele Tocchetti, et al.Current Heart Failure Reports|April 29, 2017
Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF)Valentina Sala, Jean Piero Margaria, Alessandra Murabito, et al.Annual Review of Pharmacology and Toxicology|October 6, 2020
Preventing and Treating Anthracycline Cardiotoxicity: New InsightsKonrad Teodor Sawicki, Valentina Sala, Lorenzo Prever, et al.Cells|March 26, 2025
Role of PDE4 Family in Cardiomyocyte Physiology and Heart FailureIvan Sherstnev, Aleksandra Judina, Giovanni Battista Luciani, et al.Vascular Pharmacology|July 10, 2024
Unravelling the metabolic rewiring in the context of doxorubicin-induced cardiotoxicity: Fuel preference changes from fatty acids to glucose oxidationGiulia Guerra, Michele Russo, Rebecca Priolo, et al.Pageof 11